跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 990 条关于
“Juvenile Dermatomyositis”
全部
990
临床试验
819
药物
11
机构
3
资讯
157
2年前
FDA Grants Rare Pediatric Disease Designation to Cartesian's Descartes-08 for Juvenile Dermatomyositis
去年
Cartesian Therapeutics Advances mRNA Cell Therapies for Autoimmune Diseases
8个月前
Cartesian Therapeutics Advances CAR-T Therapy Pipeline with FDA Approval for Myositis Trial and Positive Phase 3 Progress
去年
Cartesian Therapeutics' Descartes-08 Receives FDA Agreement for Phase 3 Myasthenia Gravis Trial
去年
Novel Drug Shows Promise in Reducing Dermatomyositis Disease Activity
9个月前
Galapagos' TYK2 Inhibitor GLPG3667 Meets Primary Endpoint in Dermatomyositis Phase 3-Enabling Study
去年
Brepocitinib Achieves First-Ever Positive Phase 3 Results in Dermatomyositis, Setting New Treatment Standard
去年
Miglustat Shows Promise in Stabilizing Vision in Juvenile Batten Disease
去年
FDA Expands Jylamvo Approval to Include Polyarticular Juvenile Idiopathic Arthritis and ALL
去年
FDA Grants Rare Pediatric Disease Designation to 101-PGC-005 for Systemic Juvenile Idiopathic Arthritis
第 1 页,共 16 页
上一页
下一页